Jacc Clin Electrophysiol

• 

  Publication Venue For

  • Atrial Fibrillation and Heart Failure: Too Much Talk and Not Enough Action..  9:581-582. 2023
  • Device-Related Thrombus After Left Atrial Appendage Occlusion: The Villain of the Piece..  9:108-110. 2023
  • Omnipolar Versus Bipolar Electrode Mapping in Patients With Atrial Fibrillation Undergoing Catheter Ablation..  8:1539-1552. 2022
  • Sex Differences in Sustained Ventricular Arrhythmias: A Continuing Dialogue..  8:1563-1565. 2022
  • Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial..  8:754-762. 2022
  • Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy..  8:1-11. 2022
  • The Incidence and Natural Progression of New-Onset Postoperative Atrial Fibrillation..  7:1134-1144. 2021
  • T1 Mapping in Patients With Nonischemic Cardiomyopathy Undergoing Catheter Ablation: Moving Beyond Late Gadolinium Enhancement..  7:841-842. 2021
  • Ablation of Ventricular Tachycardia Storm With Coronary Venous Ethanol..  7:682-683. 2021
  • A Bedside Intervention to Treat Ventricular Arrhythmias: Procedural Advances and Safety Considerations..  7:539-540. 2021
  • A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker..  7:502-512. 2021
  • Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease: If You Are Not Confused, You Are Not Thinking Clearly..  6:1669-1671. 2020
  • Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome..  6:1561-1570. 2020
  • Is Image Guidance for Left Ventricular Lead Targeting Overkill?.  6:1310-1312. 2020
  • Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis..  6:1144-1154. 2020
  • Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation..  6:1131-1139. 2020
  • Reply: Intracardiac Versus Transesophageal Echocardiography: If You Don't Compare Them You Don't Have the Answer..  6:881-882. 2020
  • Lead Extraction for Cardiovascular Implantable Electronic Device Infection in Patients With Left Ventricular Assist Devices..  6:672-680. 2020
  • Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation..  6:636-645. 2020
  • Direct Thrombin Inhibition During Left-Sided Catheter Ablation: More Than Just an Alternative?.  6:491-493. 2020
  • Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias..  6:562-571. 2020
  • Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study..  6:94-106. 2020
  • Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation..  5:1384-1392. 2019
  • Fidelis Replacement: Can We Abandon With Reckless Abandon?.  5:1068-1070. 2019
  • Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis..  5:599-605. 2019
  • Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance..  5:513-515. 2019
  • Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker..  5:162-170. 2019
  • Contribution of Cardiac Implantable Electronic Devices to Thrombus Formation in Patients With Chronic Thromboembolic Pulmonary Hypertension..  4:1431-1436. 2018
  • Ventricular Pacing in Single-Ventricle Complex Congenital Heart Disease: How Hard it Is to Achieve the Ideal..  4:1298-1299. 2018
  • Catheter Ablation of Mid-Myocardial Ventricular Tachycardia by Simultaneous Unipolar Radiofrequency Ablation With Half-Normal Saline Irrigation..  4:1263-1264. 2018
  • Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates..  4:1089-1102. 2018
  • Clinical Trials in Atrial Fibrillation: Lessons From the Box Score..  4:955-957. 2018
  • Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study..  4:433-444. 2018
  • Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis..  4:112-120. 2018
  • Pulmonary Vein Isolation With a Pace Capture-Guided Approach: Durable or Debatable?.  3:1272-1274. 2017
  • Reply: Are Rotors Markers of Substrate or a Mechanism of Perpetuation of Atrial Fibrillation? Increasing Data for Rotational Drivers of Human AF..  3:1340-1341. 2017
  • Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads: Data From the NCDR ICD Registry..  3:612-619. 2017
  • Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis..  3:117-126. 2017
  • Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry..  3:20-28. 2017
  • Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation..  2:703-710. 2016
  • Preventing Phrenic Nerve Injury During Second Generation Cryoballoon Ablation: What Will it Take?.  2:515-517. 2016
  • Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry..  2:355-363. 2016
  • Long QT Syndrome and Seizures..  2:277-278. 2016
  • Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry..  2:221-229. 2016
  • Practice Variation in Patients Eligible for Triple Therapy: Designing Systems to Assess Risk and Tailor Treatment..  2:44-46. 2016
  • If Some Primary Prevention Implantable Cardioverter-Defibrillator Implants Are Futile, Can We Identify Them A Priori?.  1:38-40. 2015